PRGO - Perrigo announces FDA approval of OTC equivalent of Advil Dual Action Tablets
- Perrigo <<PRGO>> has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg, the store brand OTC equivalent of Advil Dual Action Tablets 250 mg/125 mg.
- The Company anticipates launching the product by Spring 2023.
- Acetaminophen and Ibuprofen tablets provides relief for multiple pain related symptoms.
- Retail sales for the national brand equivalent product for the last twelve months ending January 29, 2023, were ~$69M based on IRI multi-outlet market data.
For further details see:
Perrigo announces FDA approval of OTC equivalent of Advil Dual Action Tablets